BioScrip, Inc. (NASDAQ:BIOS) is projected to declare fiscal fourth quarter financial results right before the stock market’s official open on March 03, 2017. The stock lost about -37.9 percent in price since last results when it was at $2.61 a share. Based on the most relevant past-periods data, there is an 60.71 percent probability for this firm’s share price to go down following next quarterly results. Earnings reaction history tells us that the equity price moved down 17 times out of last 28 reported quarters. It has beaten earnings-per-share estimates 16% of the time in its last 12 earnings reports. It fell short of earnings estimates on 10 occasions, and it has met expectations 0 time.
Here’s how traders responded to BIOS earnings announcements over the past few quarters.
BioScrip, Inc. (BIOS) Earnings Surprises & Reaction
Given its history, the average earnings announcement surprise was -42.02 percent over the past four quarters. Back on November 7, 2016, it posted earnings per-share earnings at $-0.1 which missed the consensus $-0.06 projection (negative surprise of-66.67%). For the quarter, revenue came in at 224.54M versus consensus estimate of 223.26M. The stock dropped -47.89 percent the session following the earnings reports were released, and on 7th day price change was -46.36 percent.
On August 8, 2016, it reported earnings at $-0.08 a share compared with the consensus estimate of $-0.09 per share (positive surprise of 11.11%). Revenue of 232.46M for that quarter was above the $229.58M analysts had expected. The stock retreated -0.38% the day following the earnings announcement, and on 7th day price change was 2.63%.
On May 5, 2016, it recorded $-0.15 a share in earnings which missed the consensus estimate of $-0.12 (negative surprise of -25%). Revenue for the quarter was $238.46M while analysts called for revenues to be $232.38M. The stock gained 4.31% the day following the earnings data was made public, and on 7th day price change was 1.96%.
On March 2, 2016, it announced earnings per share at $-0.15 versus the consensus estimate of $-0.08 per share (negative surprise of -87.5%). That came on revenues of $243.74M for that period. Analysts had expected $235.9M in revenue.
BioScrip, Inc. Earnings Estimates
As Q4 earnings announcement date approaches, Wall Street is expecting earnings per share of $-0.09. The analysts’ present consensus range is $-0.14-$-0.05 for EPS. The market consensus range for revenue is between $231.2M and $238.5M, with an average of $234.07M.
BioScrip, Inc. (NASDAQ:BIOS) last ended at $1.56, sending the company’s market cap near $183.59M. The consensus 12-month price target from analysts covering the stock is $2.5. The share price has declined -54.52% from its top level in 52 weeks and dropped 50% this year. It recently traded in a range of $1.54-$1.63 at a volume of 1473050 shares. The recent trading ended with the price nearly -5.45 lower for the last 5 trading days, rebounding 59.18% from its 52-week low.